Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha

Indonesian Journal of Chemistry · Vol. 15 No. 3 (2015) · hlm. 274–280

DOI
10.22146/ijc.21196
ISSN
1411-9420, 2460-1578
Terbit
2015-11-12
Penerbit
Gadjah Mada University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-nd/4.0/

Abstrak

A cyclooxygenase-2 (COX-2) inhibitor celecoxib has been previously reported to have cytotoxic activities towards gastric, prostate, ovarian, colon and breast cancer cell lines. This article reports that the cytotoxic activities of celecoxib could be resulted from its activity as a potent ligand for estrogen receptor alpha (ERα). Aided by molecular docking simulations, an in silico test to examine whether celecoxib is a ligand for estrogen receptor alpha (ERα) was performed followed by in vitro test employing cytotoxic assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method. The compound was extracted from Celebrex®. Measured by using UV spectrophotometric method at 255.5 nm, it was identified that the content of celecoxib was 102.15 mg/271.48 mg capsule content. The in silico test indicated that celecoxib is a potent ligand for ERα. This finding was confirmed experimentally by an in vitro test that celecoxib has a comparable activity as an ERα ligand to tamoxifen, a drug of choice for breast cancer treatment.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 109 tautan kepenulisan bersama · 47 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Gadjah Mada
  • Sanata Dharma University
  • Bandung Institute of Technology
  • Indonesian Institute of Sciences
  • Universitas Papua
  • Atma Jaya Catholic University of Indonesia
  • Sekolah Tinggi Ilmu Farmasi Yayasan Pharmasi Semarang
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Nunung YuniartiUniversitas Gadjah Mada5
Sudibyo MartonoUniversitas Gadjah Mada4
Rini DwiastutiSanata Dharma University4
Marchaban MarchabanUniversitas Gadjah Mada3
Agustina SetiawatiSanata Dharma University3
Zullies IkawatiUniversitas Gadjah Mada2
Vivitri Dewi PrasastyAtma Jaya Catholic University of Indonesia2
Muhammad RadifarUniversitas Gadjah Mada2
Stefanus Layli PrasojoSekolah Tinggi Ilmu Farmasi Yayasan Pharmasi Semarang2
Sudi MungkasiSanata Dharma University2
Radite YogaswaraUniversitas Papua2
Maria Ludya PulungUniversitas Papua2
Abdul MutholibInternational Islamic University Malaysia1
Jutti LevitaBandung Institute of Technology1
As’ari NawawiBandung Institute of Technology1
Iwan J. P. de EschVrije Universiteit Amsterdam1
Slamet Ibrahim SURANTAATMADJABandung Institute of Technology1
Sardjiman SardjimanUniversitas Gadjah Mada1
Perdana Adhi NugrohoUniversitas Gadjah Mada1
Aditya AsyharUniversitas Gadjah Mada1
Abdul RohmanUniversitas Gadjah Mada1
Alni DesraUniversitas Gadjah Mada1
Rinjani Mustika SariUniversitas Gadjah Mada1
Valentino ThomasUniversitas Gadjah Mada1
Suwidjiyo PramonoUniversitas Gadjah Mada1
Christofori Maria Ratna Rini NastitiSanata Dharma University1
Sri NoegrohatiUniversitas Gadjah Mada1
Harno Dwi PranowoUniversitas Gadjah Mada1
Iqmal TahirUniversitas Gadjah Mada1
Rr. Endang LukitaningsihUniversitas Gadjah Mada1
Fajar Agung Dwi HartantoAfiliasi tidak diketahui1
Dina Christin Ayuning PutriSanata Dharma University1
Maywan HarionoSanata Dharma University1
Michael Raharja GaniSanata Dharma University1
Akhmad DarmawanIndonesian Institute of Sciences1
Rizna Triana DewiIndonesian Institute of Sciences1
Yulia AnitaIndonesian Institute of Sciences1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764840418, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Computer-Aided Drug Repurposing: A Cyclooxygenase-2 Inhibitor Celecoxib as a Ligand for Estrogen Receptor Alpha</dc:title><dc:creator>Enade Perdana Istyastono</dc:creator><dc:creator>Florentinus Dika Octa Riswanto</dc:creator><dc:creator>Sri Hartati Yuliani</dc:creator><dc:subject>celecoxib</dc:subject><dc:subject>drug repurposing</dc:subject><dc:subject>estrogen receptor alpha</dc:subject><dc:subject>COX-2 inhibitors</dc:subject><dc:subject>tamoxifen</dc:subject><dc:subject>breast cancer</dc:subject><dc:subject>cytotoxicity</dc:subject><dc:subject>molecular docking</dc:subject><dc:subject>nonsteroidal anti-inflammatory drugs</dc:subject><dc:description xml:lang="en">A cyclooxygenase-2 (COX-2) inhibitor celecoxib has been previously reported to have cytotoxic activities towards gastric, prostate, ovarian, colon and breast cancer cell lines. This article reports that the cytotoxic activities of celecoxib could be resulted from its activity as a potent ligand for estrogen receptor alpha (ERα). Aided by molecular docking simulations, an in silico test to examine whether celecoxib is a ligand for estrogen receptor alpha (ERα) was performed followed by in vitro test employing cytotoxic assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) method. The compound was extracted from Celebrex®. Measured by using UV spectrophotometric method at 255.5 nm, it was identified that the content of celecoxib was 102.15 mg/271.48 mg capsule content. The in silico test indicated that celecoxib is a potent ligand for ERα. This finding was confirmed experimentally by an in vitro test that celecoxib has a comparable activity as an ERα ligand to tamoxifen, a drug of choice for breast cancer treatment.</dc:description><dc:publisher>Gadjah Mada University</dc:publisher><dc:date>2015-11-12</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://doi.org/10.22146/ijc.21196</dc:identifier><dc:identifier>10.22146/ijc.21196</dc:identifier><dc:source>Indonesian Journal of Chemistry; Vol 15 No 3 (2015); 274-280</dc:source><dc:source>1411-9420</dc:source><dc:source>2460-1578</dc:source><dc:language>en</dc:language><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights></oai_dc:dc>